A study on Siddha trial drug Pooranathi Chooranam (INT),Vali Kuthaluku Ulli Ennai (EXT)and Ottradam in patients having neck pain

An open clinical evaluation on Saganavatham (Cervical spondylosis) with siddha herbal formulation drug Pooranathi chooranam (Int), Vali kuthaluku Ulli Ennai (Ext) and Ottradam

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013642

Enrollment

Registered

2018-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Saganavatham (Cervical Spondylosis)

Interventions

Intervention1: Pooranathi chooranam (Internal),Vali kuthaluku Ulli Ennai (External).: 1-2grams of Pooranathi chooranam with honey for 48 days as internal medicine and vali kuthaluku ulli ennai for 48

Eligibility

Inclusion criteria

Inclusion criteria: 1.Complain about dull pain behind the neck in the area of trapezius 2.Radiating pain to the upper limbs 3. Numbness and weakness in arms, hands and fingers 4.Giddiness 5.Muscle spasms in neck and shoulders

Exclusion criteria

Exclusion criteria: History of 1.Cervical rib 2.Trauma 3.Spina bifida 4.Cardiac disease 5.Fracture 6.Ankylosing spondylosis (stright spine) 7.Malignancy 8.Pregnancy and Lactation 9.Tuberculosis in spine 10.Adhesive capsulitis 11.Carpal tunnel syndrome 12.Patient with any other serious systemic illness.

Design outcomes

Primary

Measure	Time frame
Outcome is reduction of pain in neck which by assessed Visual analog scale.Timepoint: 12 months	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr R Kalaivani

Government Siddha Medical College

guidesekar@gmail.com9786193863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026